No photo of Neeha Zaidi

View Scopus Profile

Neeha Zaidi

Assistant Professor

20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Neeha Zaidi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Calcineurin Medicine & Life Sciences
Osteoclasts Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Bone Chemical Compounds
Osteoblasts Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 14 Article
  • 4 Comment/debate
  • 4 Review article
  • 1 Conference contribution

Anti–CTLA-4 synergizes with dendritic cell–targeted vaccine to promote IL-3–dependent CD4 + effector T cell infiltration into murine pancreatic tumors

Zaidi, N., Quezada, S. A., Kuroiwa, J. M. Y., Zhang, L., Jaffee, E., Steinman, R. M. & Wang, B., Jan 1 2019, In : Annals of the New York Academy of Sciences.

Research output: Contribution to journal › Article

T-cells
Interleukin-3
Infiltration
Tumors
Vaccines

Dual Checkpoint Inhibition in Pancreatic Cancer: Revealing the Limitations of Synergy and the Potential of Novel Combinations

Osipov, A., Zaidi, N. & Laheru, D., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journal › Comment/debate

Pancreatic Neoplasms

Immune cells track hard-to-target brain tumours

Zaidi, N. & Jaffee, E. M., Jan 10 2019, In : Nature. 565, 7738, p. 170-171 2 p.

Research output: Contribution to journal › Comment/debate

Brain Neoplasms
Immunotherapy
Vaccines
Clinical Trials
Therapeutics

Immunotherapy transforms cancer treatment

Zaidi, N. & Jaffee, E., Jan 2 2019, In : Journal of Clinical Investigation. 129, 1, CI126046.

Research output: Contribution to journal › Comment/debate

Immunotherapy
Neoplasms
Therapeutics

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

Yarchoan, M., Albacker, L. A., Hopkins, A. C., Montesion, M., Murugesan, K., Vithayathil, T. T., Zaidi, N., Azad, N., Laheru, D., Frampton, G. M. & Jaffee, E., Mar 21 2019, In : JCI Insight. 4, 6, 126908.

Research output: Contribution to journal › Article

Open Access
Tumor Burden
Biomarkers
Neoplasms
Therapeutics